V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008005 | 240004927 | 1.71 | 64 | Curative (C) | null | 2014-04-30 | ABVD | N | N | 240035379 | AML17 TRIAL |
| 240008006 | 240004928 | null | null | Palliative (P) | 2014-09-17 | 2014-09-23 | FLAG | N | null | 240035380 | DACARBAZINE |
| 240008007 | 240004929 | 1.67 | 68 | Curative (C) | 2017-08-23 | 2017-08-24 | Sunitinib | 02 | null | 240035383 | AML18 TRIAL |
| 240008008 | 240004930 | 1.85 | null | null | 2017-04-02 | 2017-04-09 | LIPOSOMAL DAUNORUBICIN | N | Y | 240035389 | CYTARABINE + RITUXIMAB |
| 240008009 | 240004931 | 1.64 | 66.9 | Palliative (P) | 2015-07-04 | 2015-07-08 | IVA | N | Y | 240035396 | SUNITINIB |
| 240008010 | 240004932 | 1.74 | 54.4 | Curative (C) | 2015-03-02 | 2015-03-02 | CISPLATIN + FLUOROURACIL + RT | N | N | 240035403 | VINCRISTINE |
| 240008011 | 240004932 | 1.61 | 73 | Palliative (P) | 2014-03-13 | 2014-03-14 | Cisplatin + Topotecan | 02 | null | 240035403 | FLUOROURACIL + MITOMYCIN + RT |
| 240008012 | 240004933 | 1.58 | 81.9 | Palliative (P) | 2015-10-21 | 2015-11-04 | CARBOPLATIN + FLUOROURACIL | N | N | 240035410 | CARBOPLATIN + RT |
| 240008013 | 240004933 | null | 54.5 | Curative (C) | 2013-05-02 | 2013-05-07 | Bevacizumab 15mg/kg | null | N | 240035410 | CHOEP |
| 240008014 | 240004934 | 1.68 | null | Curative (C) | 2017-01-17 | 2017-01-18 | Bortezomib + MELPHALAN | N | N | 240035419 | FCR |
| 240008015 | 240004934 | 1.59 | null | Curative (C) | 2013-09-09 | 2013-09-09 | Etoposide oral | Y | N | 240035419 | CAPECITABINE + GEMCITABINE |
| 240008016 | 240004934 | 0 | 74 | Adjuvant (A) | 2017-09-13 | 2017-11-08 | Cisplatin + Etoposide po | N | N | 240035419 | FCR |
| 240008017 | 240004935 | 1.58 | 54 | Palliative (P) | 2014-02-19 | 2014-12-26 | CARBOPLATIN + FLUOROURACIL | 1 | N | 240035442 | CARBO + FLUOROURACIL |
| 240008018 | 240004935 | 0 | 77 | Palliative (P) | 2016-04-30 | 2016-05-06 | Cisplatin + Topotecan | N | N | 240035442 | PACLITAXEL + TRASTUZUMAB |
| 240008022 | 240004937 | 1.52 | null | null | 2016-11-24 | 2016-12-16 | CAPECITABINE + RT | null | N | 240035451 | VINCRISTINE |
| 240008023 | 240004938 | 1.53 | 53 | Disease modification (D) | 2014-09-28 | 2014-09-29 | CARBOPLATIN + GEMCITABINE | N | N | 240035452 | PACLITAXEL |
| 240008024 | 240004938 | 1.7 | 94.8 | Curative (C) | 2017-12-13 | 2017-12-17 | ECX | N | N | 240035452 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 240008025 | 240004939 | 1.6 | 100 | Palliative (P) | 2014-08-04 | 2014-08-09 | Bevacizumab 15mg/kg | N | N | 240035459 | CAPECITABINE |
| 240008026 | 240004940 | null | 63.5 | Disease modification (D) | 2014-03-30 | 2014-04-10 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 240035460 | MITOXANTRONE |
| 240008027 | 240004941 | null | null | Palliative (P) | 2017-07-28 | 2017-08-04 | IBRUTINIB | 2 | null | 240035462 | CAPECITABINE + RT |
| 240008028 | 240004942 | 1.45 | null | Disease modification (D) | 2015-06-05 | 2015-06-07 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240035466 | AML19 TRIAL |
| 240008029 | 240004942 | 1.75 | 97.3 | Palliative (P) | 2016-02-04 | 2016-02-04 | Cisplatin + Pemetrexed | N | N | 240035466 | CYCLOPHOSPHAMIDE |
| 240008030 | 240004943 | 1.7 | 94.7 | Palliative (P) | 2015-09-18 | 2015-10-18 | FLAG + Idarubicin | 02 | N | 240035480 | R-EPOCH |
| 240008031 | 240004943 | 1.6 | 47.9 | Palliative (P) | 2014-07-02 | 2014-07-02 | AML17 TRIAL | 02 | N | 240035480 | CHOP R + METHOTREXATE |
| 240008032 | 240004944 | 1.61 | 64.7 | Palliative (P) | 2018-10-19 | 2018-10-29 | CYCLOPHOSPHAMIDE + DEXAMETHASONE | N | N | 240035483 | CYTARABINE HIGH DOSE |
| 240008033 | 240010739 | 1.73 | 55.2 | Palliative (P) | null | 2018-10-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | N | 240035484 | GEMCITABINE |
| 240008034 | 240010739 | 1.68 | null | Palliative (P) | 2015-04-19 | 2015-05-07 | CHLVPP | N | N | 240035484 | POMALIDOMIDE |
| 240008035 | 240004945 | 1.6 | 80.8 | Curative (C) | 2016-08-30 | 2016-09-30 | ECX | N | N | 240035487 | ERIBULIN |
| 240008036 | 240004945 | 1.57 | 61.5 | Curative (C) | 2016-08-20 | 2016-08-21 | Cisplatin + Etoposide (3 day) | 02 | N | 240035487 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008037 | 240004946 | 1.77 | null | Disease modification (D) | 2014-07-10 | 2014-07-19 | CLADRIBINE | 02 | N | 240035496 | METHOTREXATE INTRATHECAL |
| 240008038 | 240004947 | 1.71 | null | null | 2015-12-19 | 2016-01-18 | CISPLATIN + VINORELBINE | N | N | 240035497 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008039 | 240004947 | 1.59 | 55.4 | Curative (C) | 2013-07-20 | 2013-07-26 | VEDex | N | N | 240035497 | PACLITAXEL |
| 240008040 | 240004947 | 1.68 | null | Palliative (P) | 2013-03-18 | 2013-04-02 | AML LI-1 Trial | N | N | 240035497 | GEMCARBO |
| 240008041 | 240014949 | 1.54 | 49 | Palliative (P) | 2015-02-07 | 2015-08-19 | FLAG + Idarubicin | N | N | 240035509 | FLAIR TRIAL |
| 240008042 | 240004948 | null | null | Curative (C) | 2016-08-14 | 2016-08-21 | mEOC TRIAL | null | null | 240035511 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240008043 | 240004949 | 1.81 | 69 | Palliative (P) | 2014-02-19 | 2014-02-20 | CYCLOPHOSPHAMIDE | 2 | N | 240035515 | CVD R |
| 240008044 | 240004949 | null | 87 | null | 2016-12-26 | 2016-12-26 | RCEOP | Y | null | 240035515 | CYTARABINE IT + METHOTREXATE |
| 240008045 | 240004950 | 1.8 | 63.2 | Palliative (P) | 2015-05-17 | 2015-05-18 | CHOEP - 14 days | 02 | N | 240035524 | ABVD |
| 240008046 | 240004950 | 1.58 | 70.1 | Curative (C) | 2013-06-01 | 2013-06-02 | FLUDARABINE | N | N | 240035524 | CISPLATIN + ETOPOSIDE |
| 240008047 | 240004951 | 1.61 | null | null | 2016-10-09 | 2016-10-10 | DOXORUBICIN | null | N | 240035529 | FLAG + IDARUBICIN |
| 240008048 | 240004952 | 1.7 | 91 | Curative (C) | null | 2013-12-04 | REMODLB TRIAL | N | N | 240035532 | IBRUTINIB |
| 240008049 | 240004952 | 1.57 | 144.9 | Curative (C) | 2017-11-11 | 2017-11-24 | Cisplatin + Etoposide + RT | N | N | 240035532 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008050 | 240004953 | null | 55.4 | Curative (C) | 2013-12-04 | 2013-12-04 | Cisplatin + Doxorubicin | null | N | 240035536 | CYTARABINE |
| 240008051 | 240004954 | null | 65.9 | Palliative (P) | 2014-08-16 | 2014-09-12 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINBLASTINE | null | N | 240035538 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 240008052 | 240004955 | 1.93 | 86 | Curative (C) | 2017-07-19 | 2017-07-20 | Docetaxel 75mg/m2 (21 day) | N | N | 240035544 | METHOTREXATE INTRATHECAL |
| 240008053 | 240004956 | 1.7 | 70.2 | null | null | 2013-08-18 | Bortezomib (weekly) | N | N | 240035547 | FLAG + IDARUBICIN |
| 240008054 | 240004956 | 1.72 | null | Palliative (P) | 2017-09-14 | 2017-09-27 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | 02 | N | 240035547 | IMATINIB |
| 240008055 | 240004957 | 1.54 | 77 | Palliative (P) | 2015-05-27 | 2015-05-28 | Cytarabine Low Dose | N | N | 240035551 | METHOTREXATE |
| 240008056 | 240004958 | 1.83 | null | null | 2014-03-23 | 2014-03-23 | ATG + Busulfan + Fludarabine | 2 | N | 240035553 | PMITCEBO R |
| 240008057 | 240004959 | 1.85 | 106 | Curative (C) | 2013-04-15 | 2013-04-15 | Cytarabine Low Dose | N | N | 240035554 | GEMCARBO |